Smokers "should avoid high-dose beta carotene supplementation" -- new ATBC analysis.
This article was originally published in The Tan Sheet
Executive Summary
HIGH-DOSE BETA CAROTENE SUPPLEMENTATION SHOULD BE AVOIDED BY SMOKERS, researchers from the Alpha-Tocopherol, Beta Carotene Cancer Prevention (ATBC) Study reported in the Nov. 6 issue of the Journal of the National Cancer Institute. The Finnish study, designed to test the assumption that beta carotene and vitamin E supplementation would reduce the incidence of lung cancer in smokers, found that the opposite was true: smokers taking beta carotene had a higher incidence of lung cancer than those who did not smoke.
You may also be interested in...
Vitamin E Supplements, Lung Cancer Risk Needs Further Review - ATBC Study
Further review of the effects of vitamin E supplementation on lung cancer risk among male smokers is recommended by Alpha-Tocopherol, Beta Carotene Cancer Prevention (ATBC) Study researchers in a report published in the Oct. 20 issue of the Journal of the National Cancer Institute.
Vitamin E Supplements, Lung Cancer Risk Needs Further Review - ATBC Study
Further review of the effects of vitamin E supplementation on lung cancer risk among male smokers is recommended by Alpha-Tocopherol, Beta Carotene Cancer Prevention (ATBC) Study researchers in a report published in the Oct. 20 issue of the Journal of the National Cancer Institute.
Vitamin E Supplements, Lung Cancer Risk Needs Further Review - ATBC Study
Further review of the effects of vitamin E supplementation on lung cancer risk among male smokers is recommended by Alpha-Tocopherol, Beta Carotene Cancer Prevention (ATBC) Study researchers in a report published in the Oct. 20 issue of the Journal of the National Cancer Institute.